Reported receipt of any non-research support from pharmaceutical manufacturers, regardless of amount, was associated with an almost doubled probability of a prostaglandin drug Rx.
New Technologies & Treatments in Eye Care—San Antonio Location: Omni La Mansion Del Rio Program Chair: Paul Karpecki, OD, FAAO Earn up to 19 COPE Credits (approval pending)
Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease Location: Canaletto Las Vegas Speakers: Nathan C. Steinle, MD and Jeffry Gerson, OD, FAAO 7:30–8:30pm PST
New Technologies & Treatments in Eye Care—Orlando Location: Hilton Orlando Buena Vista Palace Program Chair: Paul Karpecki, OD, FAAO Earn up to 19 COPE Credits (approval pending)